Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy

In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy

US Patent 6159467 · Granted Dec 12, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Organic anion transporting peptide-based cancer imaging and therapy2025
Compounds and methods to sensitize cancer cells to cisplatin2024
Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors2024
Cyanine-containing compounds for cancer imaging and treatment2023
Method of assessing disease condition of cancer2020
Organic anion transporting peptide-based cancer imaging and therapy2019
Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate2017
Targeting microRNA miR-409-3P to treat prostate cancer2017
Compositions and methods for tumor imaging and targeting by a class of organic h2017
Pan-antagonists for the androgen receptor and androgen receptor mutants associat2013
Utilization of osteocalcin promoter to deliver therapeutic genes to tumors2003
Utilization of osteocalcin promoter to deliver therapeutic genes to tumors2003